Medicare Enrolled
Dr. Barry Luskey, M.D.
Hematology & Oncology · Savannah, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Luskey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Luskey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Luskey
Dr. Barry Luskey is a hematology & oncology specialist in Savannah, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Luskey performed 1,535 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Luskey received a total of $15,870 from 82 pharmaceutical and/or device companies across 832 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Luskey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 28% volume in GA
$15,870 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,535
Medicare services
Top 28% in GA for hematology & oncology
Not available
Unique patients (not deduplicated)
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
547 | $61 | $235 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
507 | $92 | $338 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
234 | $8 | $32 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
62 | $60 | $206 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
56 | $132 | $442 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
42 | $38 | $112 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $100 | $429 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
28 | $91 | $296 |
| New patient office visit, complex (60-74 min) | 20 | $165 | $568 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $132 | $572 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,870
Total received (2018-2024)
Avg $2,267/year across 7 years
Top 21% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
832
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,367
2023
$2,144
2022
$2,979
2021
$1,751
2020
$681
2019
$2,617
2018
$2,331
Payments by company (2024)
Merck Sharp & Dohme LLC
$357
Novartis Pharmaceuticals Corporation
$239
AstraZeneca Pharmaceuticals LP
$237
PFIZER INC.
$234
Regeneron Healthcare Solutions, Inc.
$209
Daiichi Sankyo Inc.
$199
Janssen Biotech, Inc.
$189
Astellas Pharma US Inc
$145
E.R. Squibb & Sons, L.L.C.
$111
Bayer Healthcare Pharmaceuticals Inc.
$100
SEAGEN INC.
$99
Gilead Sciences, Inc.
$98
Rigel Pharmaceuticals, Inc.
$88
SOBI, INC
$75
Lilly USA, LLC
$70
Incyte Corporation
$69
Genentech USA, Inc.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$58
Celgene Corporation
$50
Alexion Pharmaceuticals, Inc.
$49
ABBVIE INC.
$47
Alnylam Pharmaceuticals Inc.
$46
Ipsen Biopharmaceuticals, Inc
$44
Eisai Inc.
$43
GlaxoSmithKline, LLC.
$41
Kite Pharma, Inc.
$40
BeiGene USA, Inc.
$39
Acrotech Biopharma Inc.
$38
ARRAY BIOPHARMA INC
$38
Pharmacosmos Therapeutics Inc.
$37
Stemline Therapeutics Inc.
$28
EMD Serono, Inc.
$27
GENZYME CORPORATION
$22
Karyopharm Therapeutics Inc.
$21
SERVIER PHARMACEUTICALS LLC
$20
JAZZ PHARMACEUTICALS INC.
$18
PUMA BIOTECHNOLOGY, INC.
$18
Aveo Pharmaceuticals, Inc.
$17
Immunocore Limited
$15
SpringWorks Therapeutics, Inc.
$14
ADC Therapeutics America, Inc.
$14
Top 3 companies account for 24.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,164
Amgen Inc.
$834
Merck Sharp & Dohme LLC
$737
Astellas Pharma US Inc
$731
Merck Sharp & Dohme Corporation
$692
E.R. Squibb & Sons, L.L.C.
$677
AstraZeneca Pharmaceuticals LP
$662
Janssen Biotech, Inc.
$647
Celgene Corporation
$604
PFIZER INC.
$586
GENZYME CORPORATION
$562
Daiichi Sankyo Inc.
$553
Genentech USA, Inc.
$520
Regeneron Healthcare Solutions, Inc.
$422
Lilly USA, LLC
$402
Incyte Corporation
$340
Seagen Inc.
$334
Takeda Pharmaceuticals U.S.A., Inc.
$293
SANOFI-AVENTIS U.S. LLC
$254
Gilead Sciences, Inc.
$254
Bayer HealthCare Pharmaceuticals Inc.
$247
Acrotech Biopharma LLC
$224
Rigel Pharmaceuticals, Inc.
$206
Global Blood Therapeutics, Inc.
$201
Ipsen Biopharmaceuticals, Inc
$184
Exelixis Inc.
$165
Bayer Healthcare Pharmaceuticals Inc.
$154
Alexion Pharmaceuticals, Inc.
$149
EISAI INC.
$135
Kite Pharma, Inc.
$135
Eisai Inc.
$129
GlaxoSmithKline, LLC.
$127
PUMA BIOTECHNOLOGY, INC.
$124
TerSera Therapeutics LLC
$121
Seattle Genetics, Inc.
$120
SEAGEN INC.
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$98
Karyopharm Therapeutics Inc.
$95
G1 Therapeutics, Inc.
$94
Puma Biotechnology, Inc.
$94
BeiGene USA, Inc.
$90
Acrotech Biopharma Inc.
$84
JAZZ PHARMACEUTICALS INC.
$78
SOBI, INC
$75
Pharmacyclics LLC, An AbbVie Company
$74
CTI BioPharma Corp.
$71
AbbVie, Inc.
$68
ABBVIE INC.
$68
Adaptive Biotechnologies Corporation
$66
Pharmacosmos Therapeutics Inc.
$61
ARRAY BIOPHARMA INC
$61
MEDIVATION FIELD SOLUTIONS LLC
$56
Taiho Oncology, Inc.
$50
Mylan Institutional Inc.
$49
SERVIER PHARMACEUTICALS LLC
$48
Stemline Therapeutics Inc.
$47
Alnylam Pharmaceuticals Inc.
$46
AMAG Pharmaceuticals, Inc.
$46
Heron Therapeutics, Inc.
$43
Jazz Pharmaceuticals Inc.
$41
Kyowa Kirin, Inc.
$41
EMD Serono, Inc.
$39
Clovis Oncology, Inc.
$35
AVEO Pharmaceuticals, Inc.
$34
TAIHO ONCOLOGY, INC.
$33
Shire North American Group Inc
$28
MorphoSys, US Inc.
$28
CSL Behring
$25
TESARO, Inc.
$24
Epizyme, Inc.,
$22
Octapharma USA, Inc.
$19
Janssen Pharmaceuticals, Inc
$19
GE HealthCare
$18
Aveo Pharmaceuticals, Inc.
$17
Immunocore Limited
$15
Emmaus Medical, Inc.
$15
SpringWorks Therapeutics, Inc.
$14
ADC Therapeutics America, Inc.
$14
NESTLE HEALTHCARE NUTRITION INC.
$14
Deciphera Pharmaceuticals Inc.
$11
Secura Bio, Inc.
$10
Sirtex Medical Inc
$7
Top 3 companies account for 17.2% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALIMTA · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Endari · Enhertu · Erleada · FASLODEX · FERAHEME · FOLOTYN · FOTIVDA · FRUZAQLA · Farydak · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Morphabond ER · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VPRIV · VYXEOS · Venclexta · Vitrakvi · Vonjo · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
11
County median income
$69,575
Nearest hospital to ZIP centroid (approximate)
CANDLER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Luskey is a clinical cardiology specialist, with above-average Medicare volume (top 28% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Luskey experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Luskey performed 547 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Luskey receive payments from pharmaceutical companies?
Yes. Dr. Luskey received a total of $15,870 from 82 companies across 832 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Luskey's costs compare to other hematology & oncology specialists in Savannah?
Dr. Luskey's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Luskey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Savannah
Browse hematology & oncology specialists in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology